Horizon Pharma plc Indenture Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
HORIZONPHARMA INVESTMENT LIMITED, as Issuer HORIZON PHARMA PUBLIC LIMITED COMPANY, as Guarantor AND U.S. BANK NATIONALASSOCIATION, as Trustee Indenture Dated as ofMarch 13, 2015...
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2015
Third Supplemental Indenture, dated March 15, 2021, by and between Viela Bio, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2021
Second Supplemental Indenture, dated April 23, 2020, by and among Horizon Properties Holding LLC, Curzion Pharmaceuticals, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2020
First Supplemental Indenture, dated November 19, 2019, by and between HZNP Finance Limited and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2020
Indenture dated as of July 16, 2019 by and between Horizon Pharma USA, Inc., the guarantors party thereto and U.S. Bank National Association, as trustee
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2019
Seventh Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2019
Third Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2019
Sixth Supplemental Indenture, dated October 31, 2018, by and between Horizon Pharma USA, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Fifth Supplemental Indenture, dated October 19, 2018, by and between Horizon Pharma Services LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Fourth Supplemental Indenture, dated October 23, 2017, by and between Horizon Pharma Tepro, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Third Supplemental Indenture, dated October 25, 2016, by and among Horizon Pharmaceutical LLC, Horizon Orphan LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Second Supplemental Indenture, dated May 10, 2016, by and between Horizon Pharma Rheumatology LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Second Supplemental Indenture, dated October 19, 2018, by and between Horizon Pharma Services LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
First Supplemental Indenture, dated October 23, 2017, by and between Horizon Pharma Tepro, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
HORIZON PHARMA, INC. and HORIZONPHARMA USA, INC. 8.750% SENIOR NOTES DUE 2024 INDENTURE Dated as of October 25, 2016 U.S. BANKNATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2016
FIRST SUPPLEMENTAL INDENTURE
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2015
HORIZON PHARMA FINANCING INC. 6.625% SENIOR NOTES DUE 2023 INDENTURE Dated as of April 29, 2015 U.S. BANKNATIONAL ASSOCIATION, Trustee TABLE OF CONTENTS
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2015
HORIZON PHARMA, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 22, 2013 5.00% Convertible Senior Notes due 2018 TABLE OF CONTENTS
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2013